Akadeum Life Sciences
Ann Arbor, US · Founded 2014 · Delaware corporation · 14 employees on LinkedIn · 12 known investors
Find your way into Akadeum Life Sciences
266 people in our graph share verified history with the Akadeum Life Sciences team — schools, employers, funds. One of them is your warm intro.
Bill Cilluffounlockedknows John Younger · together at University of Michigan (overlapped)
×4knows the team · via University of Michigan
×3knows the team · via The National Institutes of Health
knows the team · via University of Pennsylvania School of Medicine
knows the team · via University of Michigan College of Literature, Science, and the Arts
×2knows the team · via New York Angels
Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.
Founders & leadership
Akadeum Life Sciences was founded in 2014 by Kalyan Handique and John Younger.
KH
Kalyan HandiqueCo-founder
JY
John YoungerinCo-founderHe previously held NIH- and NSF-funded faculty positions at the University of Michigan, served on the National Advisory General Medical Sciences Council, and directed technology transfer investment portfolios at the University City Science Center in Philadelphia.
JM
James MilitelloExecutive
Board
JS
Jeffrey S. WilliamsBoard director
PD
Paul D'AmatoBoard director
BM
Brandon McNaughtonin𝕏Chief Executive Officer and Co-FounderA physicist and inventor, he co-founded Akadeum in 2014 after founding Life Magnetics, where he served as CTO, and holding innovator- and inventor-in-residence roles at the University of Michigan's Venture Center and Health System. He was previously an assistant research scientist in biomedical engineering at Michigan, an entrepreneur in residence with Detroit Innovate at Invest Detroit, and an entrepreneurship practicum instructor at the University of Michigan Center for Entrepreneurship.
DN
Investors · 12
Arboretum VenturesAnn Arbor · $5M – $15M
BeringeaLondon · $3M – $10M
Berkeley CatalystBerkeley
BlueStone Venture PartnersTucson · $250K – $1M
eLab VenturesAnn Arbor · $25K – $100K
ID VenturesDetroit · $50K – $250K
Invest MichiganNorthville · $100K – $250K
Kern Venture GroupBakersfield
Michigan Capital NetworkGrand Rapidsvia Jenni Li · board
Michigan RiseEast Lansing · $50K – $150K
NYBC VenturesNew York
Western Technology InvestmentPortola Valley · $250K – $30M
Reported raises · per SEC filings
Form D private placements$17.6M disclosed across 8 rounds · 2014–2026
▶$2.1MraisedJul 2026 · 9 investors · BiotechnologyRule 506(b)
▶$2.1MraisedJul 2026 · 9 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Kalyan HandiqueExecutive Officer, Director
- Paul D'AmatoDirector
- Jenni LiDirector
- James MilitelloExecutive Officer
- Offering amount
- $3.4M
- Amount sold
- $2.1M
- First sale
- Jun 2026
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$5.6MraisedApr 2025 · 35 investors · BiotechnologyRule 506(b)
▶$5.6MraisedApr 2025 · 35 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Jeffrey S. WilliamsDirector
- Paul D'AmatoDirector
- Dan KidleDirector
- Brandon McNaughtonExecutive Officer, Director
- James MilitelloExecutive Officer
- Offering amount
- $7.2M
- Amount sold
- $5.6M
- First sale
- Apr 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6MraisedMay 2023 · 22 investors · BiotechnologyRule 506(b)
▶$6MraisedMay 2023 · 22 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- William HyunDirector
- Brandon McNaughtonExecutive Officer, Director
- Dan KidleDirector
- George DunbarDirector
- John GavenonisDirector
- Offering amount
- $6.5M
- Amount sold
- $6M
- First sale
- May 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$900KraisedNov 2018 · Other Health CareRule 506(b)
▶$900KraisedNov 2018 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brandon McNaughtonExecutive Officer, Director
- John YoungerExecutive Officer, Director
- Brock SiegelDirector
- Douglas NealDirector
- Offering amount
- $2M
- Amount sold
- $900K
- Minimum investment
- $25K
- First sale
- Nov 2018
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$1.5MraisedAug 2017 · 19 investors · Other Health CareRule 506(b)
▶$1.5MraisedAug 2017 · 19 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Paul BrownDirector
- John YoungerExecutive Officer, Director
- Brandon McNaughtonExecutive Officer, Director
- William WoodDirector
- Douglas NealDirector
- Offering amount
- $1.6M
- Amount sold
- $1.5M
- First sale
- Jul 2017
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$360KraisedDec 2016 · Other Health CareRule 506(b)
▶$360KraisedDec 2016 · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John YoungerExecutive Officer, Director
- Douglas NealDirector
- Brandon McNaughtonExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $360K
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$905.1KraisedAug 2015 · 3 investors · Other Health CareRule 506(b)
▶$905.1KraisedAug 2015 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Brandon McNaughtonExecutive Officer, Director
- Douglas NealDirector
- John YoungerExecutive Officer, Director
- Offering amount
- $1M
- Amount sold
- $905.1K
- First sale
- May 2015
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
▶$150KraisedOct 2014 · 1 investors · Other Health CareRule 506(b)
▶$150KraisedOct 2014 · 1 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- John YoungerExecutive Officer, Director
- Brandon McNaughtonExecutive Officer, Director
- Offering amount
- $150K
- Amount sold
- $150K
- First sale
- Oct 2014
- Incorporated
- Corporation, Delaware, 2014
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 2
by search overlapOsmosis1901 shared keywordsOsmosis is a US health education platform of short-form medical videos and learning tools, acquired by Elsevier.
BYJU'S1664 shared keywordsBYJU'S offers online learning programs, video lessons, and a personalized learning app for students in India, including tutoring and exam-preparation programs for competitive tests such as JEE and NEET.
Companies competing with Akadeum Life Sciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Akadeum Life Sciences do?
- Akadeum manufactures GMP-compliant ancillary materials for cell and gene therapy applications, specializing in microbubble-based negative selection products. The company serves research, clinical trial, and therapeutic manufacturing environments requiring regulated cell separation products.
- Who founded Akadeum Life Sciences?
- Akadeum Life Sciences was founded by Kalyan Handique, John Younger in 2014.
- Who are Akadeum Life Sciences's investors?
- Akadeum Life Sciences's investors include Arboretum Ventures, Beringea, Berkeley Catalyst, BlueStone Venture Partners, eLab Ventures, ID Ventures, Invest Michigan, Kern Venture Group and 4 more.
- How much funding has Akadeum Life Sciences raised?
- Akadeum Life Sciences has disclosed $17.6M raised across 8 rounds.
- Where is Akadeum Life Sciences headquartered?
- Akadeum Life Sciences is headquartered in Ann Arbor, US.